Emergent BioSolutions
EBS
#6766
Rank
A$0.96 B
Marketcap
A$18.01
Share price
-1.24%
Change (1 day)
26.97%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of September 2025 : A$1.00 Billion

According to Emergent BioSolutions 's latest financial reports the company's total debt is A$1.00 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$1.06 B-15.49%
2023-12-31A$1.26 B-38.88%
2022-12-31A$2.06 B78.08%
2021-12-31A$1.16 B1.96%
2020-12-31A$1.13 B-1.82%
2019-12-31A$1.15 B2.73%
2018-12-31A$1.12 B6422.81%
2017-12-31A$17.29 M-95.35%
2016-12-31A$0.37 B9.74%
2015-12-31A$0.33 B10.5%
2014-12-31A$0.30 B341.24%
2013-12-31A$69.5 M15.07%
2012-12-31A$60.4 M4.18%
2011-12-31A$57.98 M24.19%
2010-12-31A$46.68 M-36.18%
2009-12-31A$73.15 M-9.74%
2008-12-31A$81.05 M22.31%
2007-12-31A$66.26 M22.13%
2006-12-31A$54.25 M233.33%
2005-12-31A$16.27 M-2.11%
2004-12-31A$16.62 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
A$62.62 B 6,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.88 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$36.11 B 3,498.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
A$3.96 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$92.10 B 9,076.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.84 B 2,474.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
A$0.58 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA